Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jianqun Kou"'
Autor:
Mary Eapen, Joseph H. Antin, Jakub Tolar, Sally Arai, Mitchell E. Horwitz, Jianqun Kou, Eric Leifer, John M. McCarty, Ryotaro Nakamura, Michael A. Pulsipher, Scott D. Rowley, Mary M. Horowitz, H Joachim Deeg
Publikováno v:
EClinicalMedicine, Vol 76, Iss , Pp 102819- (2024)
Summary: Background: Almost all acquired severe aplastic anaemia is immune mediated and characterised by hypocellular bone marrow and ≥2 affected haematopoietic lineages. The optimal preparartive regimen for unrelated donor transplantation remains
Externí odkaz:
https://doaj.org/article/727f09c81ccf402580493c5681107953
Autor:
Brent R. Logan, Denggang Fu, Alan Howard, Mingwei Fei, Jianqun Kou, Morgan R. Little, Djamilatou Adom, Fathima A. Mohamed, Bruce R. Blazar, Philip R. Gafken, Sophie Paczesny
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 15 (2023)
BACKGROUND Chronic graft-versus-host disease (cGVHD) is a serious complication of allogeneic hematopoietic cell transplantation (HCT). More accurate information regarding the risk of developing cGVHD is required. Bone marrow (BM) grafts contribute to
Externí odkaz:
https://doaj.org/article/a11b421307fe47d08b958d9f48b3ac8c
Autor:
Joshua A. Hill, Michael J. Martens, Jo-Anne H. Young, Kavita Bhavsar, Jianqun Kou, Min Chen, Lik Wee Lee, Aliyah Baluch, Madhav V. Dhodapkar, Ryotaro Nakamura, Kristin Peyton, Zainab Shahid, Paul Armistead, Peter Westervelt, John McCarty, Joseph McGuirk, Mehdi Hamadani, Susan DeWolf, Kinga Hosszu, Elad Sharon, Ashley Spahn, Amir A. Toor, Stephanie Waldvogel, Lee M. Greenberger, Jeffery J. Auletta, Mary M. Horowitz, Marcie L. Riches, Miguel-Angel Perales
Publikováno v:
EClinicalMedicine, Vol 59, Iss , Pp 101983- (2023)
Summary: Background: The optimal timing for SARS-CoV-2 vaccines within the first year after allogeneic hematopoietic cell transplant (HCT) is poorly understood. Methods: We conducted a prospective, multicentre, observational study of allogeneic HCT r
Externí odkaz:
https://doaj.org/article/a2cc05e4a2e64efe8623333b71cfde7b
Autor:
Jacqueline M Lauer, Miles A Kirby, Alfa Muhihi, Nzovu Ulenga, Said Aboud, Enju Liu, Robert K M Choy, Michael B Arndt, Jianqun Kou, Wafaie Fawzi, Andrew Gewirtz, Christopher R Sudfeld, Karim P Manji, Christopher P Duggan
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 17, Iss 3, p e0011181 (2023)
BackgroundEnvironmental enteric dysfunction (EED) may contribute to poor growth and development in young children. While validated EED biomarkers are currently lacking, multiplex assays are able to capture multiple domains of the condition. The purpo
Externí odkaz:
https://doaj.org/article/bb5f9565f3b54a0b851aaf5bf6a39d35
Autor:
Miles A. Kirby, Jacqueline M. Lauer, Alfa Muhihi, Nzovu Ulenga, Said Aboud, Enju Liu, Robert K.M. Choy, Michael B. Arndt, Jianqun Kou, Andrew Gewirtz, Wafaie W. Fawzi, Christopher P. Duggan, Karim P. Manji, Christopher R. Sudfeld
Publikováno v:
EBioMedicine, Vol 84, Iss , Pp 104257- (2022)
Summary: Background: Environmental enteric dysfunction (EED) may contribute to adverse birth outcomes in low-resource settings. We examined the associations of EED biomarkers with birth outcomes in pregnant women living with human immunodeficiency vi
Externí odkaz:
https://doaj.org/article/d42fed4a88f24ed0837f4b1778292e67
Autor:
Jianqun Kou, Phillip R. Musich, Ben Staal, Liang Kang, Yuan Qin, Zhi Q. Yao, Boheng Zhang, Weizhong Wu, Angela Tam, Alan Huang, Huai-Xiang Hao, George F. Vande Woude, Qian Xie
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-13 (2018)
Abstract Background Aberrant MET tyrosine kinase signaling is known to cause cancer initiation and progression. While MET inhibitors are in clinical trials against several cancer types, the clinical efficacies are controversial and the molecular mech
Externí odkaz:
https://doaj.org/article/e7bf11f0134e423c8693699756a8d3d7
Autor:
Jeffery J. Auletta, Jianqun Kou, Min Chen, Yung-Tsi Bolon, Larisa Broglie, Caitrin Bupp, Debra Christianson, Rachel N. Cusatis, Steven M. Devine, Mary Eapen, Mehdi Hamadani, Mary Hengen, Stephanie J. Lee, Amy Moskop, Kristin M. Page, Marcelo C. Pasquini, Waleska S. Perez, Rachel Phelan, Marcie L. Riches, J. Douglas Rizzo, Wael Saber, Stephen R. Spellman, Heather E. Stefanski, Patricia Steinert, Eileen Tuschl, Rafeek Yusuf, Mei-Jie Zhang, Bronwen E. Shaw
Publikováno v:
Transplantation and Cellular Therapy. 29:346.e1-346.e10
Autor:
Jacqueline Lauer, Miles Kirby, Alfa Muhihi, Nzovu Ulenga, Said Aboud, Enju Liu, Robert K.M Choy, Jianqun Kou, Andrew Gewirtz, Wafaie Fawzi, Christopher Sudfeld, Karim Manji, Christopher Duggan
Publikováno v:
Current Developments in Nutrition. 6:589
Autor:
Miles Kirby, Jacqueline Lauer, Alfa Muhihi, Nzovu Ulenga, Said Aboud, Enju Liu, Robert Choy, Jianqun Kou, Andrew Gewirtz, Wafaie Fawzi, Christopher Duggan, Christpher Sudfeld, Karim Manji
Publikováno v:
Current Developments in Nutrition. 6:676
Autor:
Yuan Qin, David A. Largaespada, Anna Qin, Craig A. Land, Anna Musket, Qian Xie, Ben Staal, Kirk Tanner, Johanna Preiszner, Liang Kang, Jianqun Kou, Yong Jiang, Barbara R. Tschida, John B. Schweitzer
Publikováno v:
Neuro-oncology Advances
Background Aberrant MET receptor tyrosine kinase (RTK) activation leads to invasive tumor growth in different types of cancer. Overexpression of MET and its ligand hepatocyte growth factor (HGF) occurs more frequently in glioblastoma (GBM) than in lo